- Entry
- $3.12
- Now
- $2.88 -7.7%
- Target
- —
- Score
- —
CAPR I wrote up at $4.20 after the 9-3 negative AdCom and around 80% drop in 3 sessions. I thought FDA would probably say no. Instead FDA extended the PDUFA to Nov 22 after CAPR submitted another year of HOPE-3 follow up and narrowed the label to upper limb function. Its around $9.40 now. So I had the mechanism right and probability wrong. Being wrong in the direction that pays is still being wrong. Ran the screen again this weekend. …
— ORIGINAL POST ·
wanted to share my bio wins
· r/smallstreetbets
· Sep 8, 2026